Literature DB >> 6776197

Induction and regulation of immunoglobulin expression in a murine pre-B cell line, 70Z/3. I. Cell cycle-associated induction of sIgM expression and kappa-chain synthesis in 70Z/3 cells by LPS stimulation.

N Sakaguchi, T Kishimoto, H Kikutani, T Watanabe, N Yoshida, A Shimizu, Y Yamawaki-Kataoka, T Honjo, Y Yamamura.   

Abstract

Stimulation of a murine pre-B cell line, 70Z/3, with LPS induced sIgM expression and an increase of L kappa-chain mRNA within 12 hr. In synchronized 70Z/3 cells, the cell division cycle was 10 to 11 hr and LSP-stimulation did not affect the cell division cycle. LPS-signals given at G1/S boundary induced sIgM expression in the G2 to M-phase. On the other hand, LPS-signals given after M-phase did not induce sIgM expression. Inhibition of cell division with demecorcin did not affect sIgM expression in the M-phase. Induction of intracellular kappa-chain synthesis was also observed in the G2 to M-phase when the LPS-stimulation was provided at G1/S boundary, but LPS-signals given after the M-phase did not induce de novo synthesis of kappa-chain. These results showed that LPS-induced sIgM expression and synthesis of kappa-chain were cell cycle-related events and sIgM expression was associated wih de novo synthesis of kappa-chain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776197

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies.

Authors:  Patrick A Zweidler-McKay; Yiping He; Lanwei Xu; Carlos G Rodriguez; Fredrick G Karnell; Andrea C Carpenter; Jon C Aster; David Allman; Warren S Pear
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

2.  A labile inhibitor blocks immunoglobulin kappa-light-chain-gene transcription in a pre-B leukemic cell line.

Authors:  R Wall; M Briskin; C Carter; H Govan; A Taylor; P Kincade
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

3.  Mediators from cloned T helper cell lines affect immunoglobulin expression by B cells.

Authors:  C J Paige; M H Schreier; C L Sidman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

4.  Activation of glomerular mesangial cells by gram-negative bacterial cell wall components.

Authors:  D H Lovett; S L Bursten; D Gemsa; W Bessler; K Resch; J L Ryan
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein.

Authors:  F Shirakawa; M Chedid; J Suttles; B A Pollok; S B Mizel
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

6.  Investigation of guanine-nucleotide-binding protein involvement and regulation of cyclic AMP metabolism in interleukin 1 signal transduction.

Authors:  K Ray; N Thompson; N Kennard; P Rollins; S Grenfell; S Witham; N Smithers; R Solari
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

7.  Organization of the murine Ig-related lambda 5 gene transcribed selectively in pre-B lymphocytes.

Authors:  A Kudo; N Sakaguchi; F Melchers
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

8.  Isolation of a cDNA copy of an RNA species expressed in murine pre-B cells.

Authors:  N Sakaguchi; C N Berger; F Melchers
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

9.  A novel, inducible and T cell-specific enhancer located at the 3' end of the T cell receptor alpha locus.

Authors:  A Winoto; D Baltimore
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

10.  The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines.

Authors:  M Macchi; J M Bornert; I Davidson; M Kanno; R Rosales; M Vigneron; J H Xiao; C Fromental; P Chambon
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.